Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 128
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
VANCOUVER, BC, Jan. 21, 2025 ~ Las Vegas, NV - Human in Motion Robotics, a global leader in robotic mobility and humanoid technology, has made a groundbreaking leap in the field of rehabilitation technology with their latest product, XoMotion™. This innovative medical exoskeleton was recently named the Top Robot at CES 2025 by USA Today.
CES 2025, held from January 7-10 in Las Vegas, brought together the brightest minds in technology to showcase cutting-edge innovations from around the world. Among these impressive displays was XoMotion, which received widespread recognition from attendees, media outlets, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.
The success of Human in Motion Robotics' exhibition at CES 2025 was highlighted by several key achievements. XoMotion received accolades from visitors and industry leaders alike, including a CES 2025 Innovations Award that solidified its position as a shining example of human-centered technological innovation. Attendees were also able to experience firsthand the self-balancing, hands-free, and natural motion capabilities of XoMotion through product demonstrations. These demonstrations were attended by individuals with mobility challenges as well as therapists and physicians who were impressed by the exoskeleton's ability to empower users with independence and enhance care.
More on nvtip.com
Investors and partners were also engaged by the platform technology and multidisciplinary expertise of Human in Motion Robotics. This led to exciting opportunities for future growth and advancements for XoMotion beyond just rehabilitation purposes.
The event also marked another milestone for Human in Motion Robotics as they continue to make strides towards improving the lives of those with mobility impairments. The connections made during CES will drive future advancements and growth for the company.
One of the key highlights of the exhibition was meeting Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.
For those interested in learning more about XoMotion and Human in Motion Robotics, interviews with Chloë or a full press kit can be requested by contacting Phil Astrachan, VP of Marketing at 415-310-7466.
XoMotion's innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.
More on nvtip.com
Some key features of XoMotion include its self-balancing capabilities, which ensure stability and safety during use with 12 high-performance actuators that replicate natural bipedal movement. It also allows for hands-free upper-body functionality, enhancing usability. The exoskeleton is capable of complex ambulatory tasks and offers true functionality in all directions. Designed to aid patients at various stages of recovery, including spinal cord injuries, strokes, and other neurological impairments, XoMotion is also therapist-friendly as it reduces physical strain on therapists and allows them to focus on patient care.
Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. Currently available for acquisition by rehabilitation facilities in Canada, the device is also available for scientific investigators conducting rehabilitation or robotics research worldwide. Clinical trials are currently underway for FDA approval in the United States with plans to expand its reach to other global markets such as Europe and Asia.
For more information or to request a demonstration of XoMotion, please visit humaninmotion.com or contact Human in Motion Robotics directly through their website.
CES 2025, held from January 7-10 in Las Vegas, brought together the brightest minds in technology to showcase cutting-edge innovations from around the world. Among these impressive displays was XoMotion, which received widespread recognition from attendees, media outlets, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.
The success of Human in Motion Robotics' exhibition at CES 2025 was highlighted by several key achievements. XoMotion received accolades from visitors and industry leaders alike, including a CES 2025 Innovations Award that solidified its position as a shining example of human-centered technological innovation. Attendees were also able to experience firsthand the self-balancing, hands-free, and natural motion capabilities of XoMotion through product demonstrations. These demonstrations were attended by individuals with mobility challenges as well as therapists and physicians who were impressed by the exoskeleton's ability to empower users with independence and enhance care.
More on nvtip.com
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
Investors and partners were also engaged by the platform technology and multidisciplinary expertise of Human in Motion Robotics. This led to exciting opportunities for future growth and advancements for XoMotion beyond just rehabilitation purposes.
The event also marked another milestone for Human in Motion Robotics as they continue to make strides towards improving the lives of those with mobility impairments. The connections made during CES will drive future advancements and growth for the company.
One of the key highlights of the exhibition was meeting Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.
For those interested in learning more about XoMotion and Human in Motion Robotics, interviews with Chloë or a full press kit can be requested by contacting Phil Astrachan, VP of Marketing at 415-310-7466.
XoMotion's innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.
More on nvtip.com
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
Some key features of XoMotion include its self-balancing capabilities, which ensure stability and safety during use with 12 high-performance actuators that replicate natural bipedal movement. It also allows for hands-free upper-body functionality, enhancing usability. The exoskeleton is capable of complex ambulatory tasks and offers true functionality in all directions. Designed to aid patients at various stages of recovery, including spinal cord injuries, strokes, and other neurological impairments, XoMotion is also therapist-friendly as it reduces physical strain on therapists and allows them to focus on patient care.
Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. Currently available for acquisition by rehabilitation facilities in Canada, the device is also available for scientific investigators conducting rehabilitation or robotics research worldwide. Clinical trials are currently underway for FDA approval in the United States with plans to expand its reach to other global markets such as Europe and Asia.
For more information or to request a demonstration of XoMotion, please visit humaninmotion.com or contact Human in Motion Robotics directly through their website.
Filed Under: Business
0 Comments
Latest on nvtip.com
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- Delirious Comedy Club And House Of Magic Expand To New Larger Location At Silver Sevens
- Valhallan Esports and XP League Unite to Expand Opportunity in Youth Esports
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Snell & Wilmer Attorney Caylye Nordling Joins Board of Directors of SafeNest
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030